3

FORM 3 SUBMISSION

Company: AGIOS PHARMACEUTICALS, INC.
Filed: July 23, 2013
Period of Report: July 23, 2013
Accession Number: 0001209191-13-037559

View Document ↗ View on SEC.gov ↗